Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02309580
Title Study of Ibrutinib in Relapsed and Refractory T-cell Lymphoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

lymphoma

Therapies

Ibrutinib

Age Groups: adult
Covered Countries USA


No variant requirements are available.